Every recall we track for Life Technologies Corporation — 12 in all — plus the complaints and injury reports the public filed about them.
Life Technologies recalls Torrent Suite Dx Software versions 5.14 and earlier for Ion PGM DX Systems. Exploitation could allow attackers to alter settings, configurations, or data on the instrument.
Life Technologies recalls The TaqPath RT-PCR COVID-19 Kit software v1.2 due to risk of false negatives and positives. Affected units may need retesting or correction.
Life Technologies recalls specific versions of their COVID-19 test software due to potential false negatives and false positives, which could lead to inaccurate test results and increased retesting.
Life Technologies recalls Oncomine Dx Target Test RNA Control for NSCLC detection due to extended expiration date prior to clearance. Affected units have specific lot codes and catalog numbers. Contact for remedy details.
Life Technologies recalls Ion Torrent Dx No Template Control Kit for DNA/RNA detection in lung cancer tests due to incorrect expiration dates. The kit may expire earlier than approved, risking inaccurate test results.
Life Technologies recalls Oncomine Dx Target Test RNA/DNA Panel for NSCLC detection due to extended expiration date prior to clearance. Affected lots may expire before intended use.
Life Technologies recalls Oncomine Dx Target Test DNA Control-IVD for NSCLC detection due to extended expiration date prior to clearance. Affected lots may expire before intended use.
Life Technologies recalls CTSTM Essential 8 Medium tubes with untested supplier components. Affected lots expired by Jan 2020. No remedy specified in official notice.
Life Technologies recalls StemPro MSC SFM CTS devices with specific lot numbers due to untested supplier components. Affected units may have adventitious agents that could pose health risks.
Life Technologies recalls two cancer test kits due to potential false negatives in ROS1 fusion detection, which could lead to incorrect treatment decisions.
Life Technologies recalls three lots of Human Fetal Hemoglobin FITC Conjugate due to potential false positives in tests. Affected units may cause incorrect results in patient samples and controls.
Life Technologies recalls Oncomine Dx Target Test User Guides and Assay Definition Files for non-small cell lung cancer tests. These may report incorrect results when used on samples other than NSCLC tumors.
